BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38842810)

  • 1. Outcomes of Bypass Surgery in Adult Moyamoya Disease by Onset Type.
    Lim YC; Lee E; Song J
    JAMA Netw Open; 2024 Jun; 7(6):e2415102. PubMed ID: 38842810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults.
    Jang DK; Lee KS; Rha HK; Huh PW; Yang JH; Park IS; Ahn JG; Sung JH; Han YM
    J Neurosurg; 2017 Sep; 127(3):492-502. PubMed ID: 27834597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome in adult patients with hemorrhagic moyamoya disease after combined extracranial-intracranial bypass.
    Jiang H; Ni W; Xu B; Lei Y; Tian Y; Xu F; Gu Y; Mao Y
    J Neurosurg; 2014 Nov; 121(5):1048-55. PubMed ID: 25127415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct versus indirect bypasses for adult ischemic-type moyamoya disease: a propensity score-matched analysis.
    Deng X; Gao F; Zhang D; Zhang Y; Wang R; Wang S; Cao Y; Zhao Y; Pan Y; Liu X; Zhang Q; Zhao J
    J Neurosurg; 2018 Jun; 128(6):1785-1791. PubMed ID: 28799875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.
    Liu XJ; Zhang D; Wang S; Zhao YL; Teo M; Wang R; Cao Y; Ye X; Kang S; Zhao JZ
    J Neurosurg; 2015 Feb; 122(2):392-9. PubMed ID: 25423267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Encephaloduroarteriosynangiosis for hemorrhagic moyamoya disease: long-term outcome of a consecutive series of 95 adult patients from a single center.
    Wang QN; Bao XY; Zhang Y; Zhang Q; Li DS; Duan L
    J Neurosurg; 2019 Jun; 130(6):1898-1905. PubMed ID: 29999465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical course of asymptomatic adult moyamoya disease.
    Jo KI; Yeon JY; Hong SC; Kim JS
    Cerebrovasc Dis; 2014; 37(2):94-101. PubMed ID: 24435045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical outcomes following encephaloduroarteriosynangiosis in North American adults with moyamoya.
    Agarwalla PK; Stapleton CJ; Phillips MT; Walcott BP; Venteicher AS; Ogilvy CS
    J Neurosurg; 2014 Dec; 121(6):1394-400. PubMed ID: 25280094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stroke prevention by direct revascularization for patients with adult-onset moyamoya disease presenting with ischemia.
    Kim T; Oh CW; Kwon OK; Hwang G; Kim JE; Kang HS; Cho WS; Bang JS
    J Neurosurg; 2016 Jun; 124(6):1788-93. PubMed ID: 26636391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revascularization Surgery in Patients with Ischemic-Type Moyamoya Disease: Predictors for Postoperative Stroke and Long-Term Outcomes.
    Yu L; Ma L; Huang Z; Shi Z; Wang R; Zhao Y; Zhang D
    World Neurosurg; 2019 Aug; 128():e582-e596. PubMed ID: 31059856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up results in 142 adult patients with moyamoya disease according to management modality.
    Lee SB; Kim DS; Huh PW; Yoo DS; Lee TG; Cho KS
    Acta Neurochir (Wien); 2012 Jul; 154(7):1179-87. PubMed ID: 22476796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late (5-20 years) outcomes after STA-MCA anastomosis and encephalo-duro-myo-arterio-pericranial synangiosis in patients with moyamoya disease.
    Kuroda S; Nakayama N; Yamamoto S; Kashiwazaki D; Uchino H; Saito H; Hori E; Akioka N; Kuwayama N; Houkin K
    J Neurosurg; 2020 Mar; 134(3):909-916. PubMed ID: 32168480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Operative and Conservative Treatment for Asymptomatic Moyamoya Disease: Preliminary Experience in Small Retrospective Series.
    Zeng H; Guo Y; Li Y; Yu X; Yan F; Tan X; Xu H; Peng Y; Zhuang J; Zhou H; Fu X; Wang L; Chen G
    World Neurosurg; 2021 Feb; 146():e955-e960. PubMed ID: 33217589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superficial temporal artery-to-middle cerebral artery bypass in combination with indirect revascularization in moyamoya patients ≤ 3 years of age.
    Bot GM; Burkhardt JK; Gupta N; Lawton MT
    J Neurosurg Pediatr; 2018 Nov; 23(2):198-203. PubMed ID: 30497164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel system for evaluating collateralization of the external carotid artery after cerebral revascularization in moyamoya disease.
    Li W; Zhao M; Liu X; Wang P; Zhu H; Zhang Q; Zhu C; Zhang Q; Zhao J; Zhang Y
    J Neurosurg; 2024 Jun; 140(6):1707-1715. PubMed ID: 38157529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct vs Indirect Revascularization in a North American Cohort of Moyamoya Disease.
    Lai PMR; Patel NJ; Frerichs KU; Patel AB; Aziz-Sultan MA; Ogilvy CS; Du R
    Neurosurgery; 2021 Jul; 89(2):315-322. PubMed ID: 33957674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Outcome After Conservative Treatment and Direct Bypass Surgery of Moyamoya Disease at Late Suzuki Stage.
    Ge P; Zhang Q; Ye X; Liu X; Deng X; Li H; Wang R; Zhang Y; Zhang D; Zhao J
    World Neurosurg; 2017 Jul; 103():283-290. PubMed ID: 28366750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Surgical Treatment on the Recurrent Stroke Prevention for Adult Patients With Hemorrhagic Moyamoya Disease.
    Wang G; Zhang X; Feng M; Liu X; Guo F
    J Craniofac Surg; 2017 Nov; 28(8):2113-2116. PubMed ID: 29088693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Surgery for Moyamoya Is Not Associated with Worse Outcomes: Analysis of a North American Adult Cohort.
    Reed LK; Soto JM; Benardete EA
    World Neurosurg; 2023 Jun; 174():e53-e61. PubMed ID: 36871651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features, surgical treatment and long-term outcome in adult patients with Moyamoya disease in China.
    Bao XY; Duan L; Li DS; Yang WZ; Sun WJ; Zhang ZS; Zong R; Han C
    Cerebrovasc Dis; 2012; 34(4):305-13. PubMed ID: 23146868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.